SynthesisJournal of the Association for Research in Otolaryngology : JARO2026
A Systematic Review of Genes Affecting Endocochlear Potential.
Synthesis in Journal of the Association for Research in Otolaryngology : JARO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purposeHearing loss is highly heterogeneous. Any one of hundreds of genes and dozens of cell types can be involved in the pathological processes in the auditory system. One class of hearing loss results from a reduction of the endocochlear potential (EP), a voltage maintained in the endolymph that bathes the upper surface of the sensory hair cells in the cochlea. Understanding the landscape of genes involved in reduced EP will be useful in developing targeted therapies for this type of hearing loss. Here we review these genes.
methodsResearch articles that report genes impacting EP in mutant mice were collated using several different approaches. Cell type-specific expression and patterns in their biological function were investigated.
resultsWe report 55 genes associated with reduced EP as well as 43 genes shown to underlie deafness but with no change in EP. We show that of these 55 reduced EP genes, 27 are linked to deafness in humans and therefore these patient populations are candidates for having a reduced EP. We demonstrate that the expression of reduced EP genes is not clustered to a particular cell type within the stria vascularis or organ of Corti.
conclusionThis analysis highlights the broad range of expression patterns and functions of genes involved in generating and maintaining the mammalian EP. Furthermore, the lists presented here can inform the direction of translational research for different forms of human hearing loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.